Retrospective Study
Copyright ©The Author(s) 2020.
World J Rheumatol. Dec 28, 2020; 10(1): 1-10
Published online Dec 28, 2020. doi: 10.5499/wjr.v10.i1.1
Figure 1
Figure 1 True/false questions regarding various aspects of biosimilars.
Figure 2
Figure 2 The percentage of survey respondents who provided the correct answer regarding various aspects of shared decision-making.
Figure 3
Figure 3 Motivation to learn more about biosimilars and shared decision-making as well as interest in discussing each subject with others (e. g., medical professionals, family members, friends).
Figure 4
Figure 4 The responses to the question “What would be your preferred style to learn more about biosimilar agents and shared decision-making?”.